|

Zee Live News News, World's No.1 News Portal

LIVE NEWS
Annuities are coming to more 401(k) plans. Should workers embrace them?More than a month into DR Congo Ebola outbreak, doctors warn ‘this epidemic will last’A maple leaf-shaped ‘Canadian clapper’ sparks buzz across TorontoMirabai Chanu to Lead India’s Weightlifting Team at Commonwealth Games 2026, Full Squad AnnouncedWill Meghan Markle’s Presence At Prince Harry’s Reunion With King Charles Change Things?Annuities are coming to more 401(k) plans. Should workers embrace them?More than a month into DR Congo Ebola outbreak, doctors warn ‘this epidemic will last’A maple leaf-shaped ‘Canadian clapper’ sparks buzz across TorontoMirabai Chanu to Lead India’s Weightlifting Team at Commonwealth Games 2026, Full Squad AnnouncedWill Meghan Markle’s Presence At Prince Harry’s Reunion With King Charles Change Things?

Therapeutics

UBS reiterates Denali Therapeutics stock rating citing Avlayah launch

UBS reiterates Denali Therapeutics stock rating citing Avlayah launch

admin_zeelivenews

Spyre Therapeutics to Participate in Upcoming June Investor Conferences

Spyre Therapeutics to Participate in Upcoming June Investor Conferences

admin_zeelivenews

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

admin_zeelivenews

Fredun enters high-value hormone therapeutics segment with new speciality brand launch

Fredun enters high-value hormone therapeutics segment with new speciality brand launch

admin_zeelivenews

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

admin_zeelivenews

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

admin_zeelivenews

Protagonist Therapeutics Jumps 7.0% in Broad Rally – Alphastreet

Protagonist Therapeutics Jumps 7.0% in Broad Rally – Alphastreet

admin_zeelivenews

Apogee Therapeutics (APGE) CMO sells shares worth 6,619

Apogee Therapeutics (APGE) CMO sells shares worth $466,619

admin_zeelivenews

Oppenheimer raises Palvella Therapeutics price target on valuation

Oppenheimer raises Palvella Therapeutics price target on valuation

admin_zeelivenews

Avalo Therapeutics 2025 Financial Review – Alphastreet

Avalo Therapeutics 2025 Financial Review – Alphastreet

admin_zeelivenews

Next

Plugin developed by ProSEOBlogger
Facebook
Telegram
Telegram
Plugin developed by ProSEOBlogger. Get free Ypl themes.
Plugin developed by ProSEOBlogger. Get free gpl themes